ASCO GUIDELINES Bundle

Advanced Ovarian Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/770598

Contents of this Issue

Navigation

Page 5 of 5

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2016 All rights reserved Disclaimer is pocket card is derived om recommendations in the American Society of Clinical Oncology Guideline. is resource is a practice tool based on ASCO ® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. is pocket card does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. e practice guidelines and additional information are available at www.asco.org/NACT-ovarian-guideline. Copyright © 2016 by American Society of Clinical Oncology. All rights reserved. ASCOOVA16112 Abbreviations ASCO, American Society of Clinical Oncolog y; CT, computed tomography; NACT, neoadjuvant chemotherapy; PCS, primary cytoreductive surgery Source Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncolog y and American Society of Clinical Oncolog y Clinical Practice Guideline. J Clin Oncol. 2016 Oct 1;34(28):3460-73. Recommendation Grading Type Benefit/harm Evidence Quality Strength Of Recommendation EB Evidence-based B Benefits outweigh harms H High Strong CB Consensus- based H Harms outweigh benefits I Intermediate Moderate L Low Weak ASCO believes that cancer clinical trials are vital to inform medical decisions and improve cancer care and that all patients should have the opportunity to participate. Additional information, which may include data supplements, slide sets, patient versions, frequently asked questions, and other clinical tools and resources, is available at www.asco.org/NACT-ovarian-guideline and www.asco.org/guidelineswiki

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Advanced Ovarian Cancer